Enhancing the therapeutic efficacy of gefitinib on subcutaneously transplanted SKOV3 ovarian cancer tumors in nude mice via ultrasound‑stimulated microbubble cavitation-Reference-Cited by-同舟云学术

Enhancing the therapeutic efficacy of gefitinib on subcutaneously transplanted SKOV3 ovarian cancer tumors in nude mice via ultrasound‑stimulated microbubble cavitation

Published:2024-06-26 Issue:3 Volume:28 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Chen Jianghong¹,Wang Juan²,Yan Xiaonan³,Zhang Xiaolin⁴,Zhang Zhengzheng⁵,Li Hui⁶,Wang Yueheng⁷

Affiliation:

1. Department of Ultrasound, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050030, P.R. China

2. Department of Abdominal Ultrasound, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China

3. Department of Obstetrics and Gynecology Ultrasound, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China

4. Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Hebei Province Key Laboratory of Environment and Human Health, Shijiazhuang, Hebei 050017, P.R. China

5. Department of Immunology, Hebei Medical University, Key Laboratory of Immune Mechanism and Intervention for Serious Diseases in Hebei Province, Shijiazhuang, Hebei 050017, P.R. China

6. Department of Ultrasound, Xinqiao Hospital, Army Medical University, Chongqing 400037, P.R. China

7. Department of Cardiac Ultrasound, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China

Publisher

Spandidos Publications

Reference36 articles.

1. Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management;Khan;Semin Cancer Biol,2021

2. Treatment of epithelial ovarian cancer;Kuroki;BMJ,2020

3. Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cells;Ohta;Cancer Biol Ther,2012

4. Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer;Chelariu-Raicu;Int J Gynecol Cancer,2020

5. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells;Thibault;J Ovarian Res,2017